Royal Bank Of Canada Avidity Biosciences, Inc. Transaction History

Royal Bank Of Canada

$528 Billion
Q2 2025

A detailed history of Royal Bank Of Canada transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 606,707 shares of RNA stock, worth $28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

606,707

Previous 44,304 1269.42%

Holding current value

$28 Million

Previous $1.31 Million 1218.29%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$24.08 - $36.24 $13.5 Million - $20.4 Million	562,403 Added 1269.42%	606,707 $17.2 Million
Q1 2025 May 15, 2025	BUY	$27.05 - $35.11 $331,119 - $429,781	12,241 Added 38.18%	44,304 $1.31 Million
Q4 2024 Feb 14, 2025	SELL	$29.08 - $52.5 $567,612 - $1.02 Million	-19,519 Reduced 37.84%	32,063 $932,000
Q3 2024 Nov 14, 2024	BUY	$37.21 - $48.14 $1.54 Million - $2 Million	41,473 Added 410.26%	51,582 $2.37 Million
Q2 2024 Aug 14, 2024	BUY	$22.73 - $40.85 $158,428 - $284,724	6,970 Added 222.05%	10,109 $412,000
Q1 2024 Nov 05, 2024	SELL	$9.16 - $25.52 $63,845 - $177,874	-6,970 Reduced 68.95%	3,139 $80,000
Q1 2024 May 15, 2024	SELL	$9.16 - $25.52 $190,573 - $530,943	-20,805 Reduced 86.89%	3,139 $80,000
Q4 2023 Feb 14, 2024	BUY	$4.87 - $9.37 $57,738 - $111,090	11,856 Added 98.08%	23,944 $216,000
Q3 2023 Nov 14, 2023	BUY	$6.3 - $11.35 $27,808 - $50,098	4,414 Added 57.52%	12,088 $77,000
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $34,833 - $56,875	3,280 Added 74.65%	7,674 $85,000
Q1 2023 May 15, 2023	SELL	$15.35 - $25.65 $44,376 - $74,154	-2,891 Reduced 39.68%	4,394 $67,000
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $60,792 - $136,934	6,043 Added 486.55%	7,285 $161,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $13,419 - $20,337	868 Added 232.09%	1,242 $20,000
Q2 2022 Aug 15, 2022	SELL	$11.18 - $20.5 $27,256 - $49,979	-2,438 Reduced 86.7%	374 $5,000
Q1 2022 May 16, 2022	SELL	$14.2 - $23.78 $72,604 - $121,587	-5,113 Reduced 64.52%	2,812 $52,000
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $2,754 - $3,869	135 Added 1.73%	7,925 $189,000
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $17,143 - $23,798	944 Added 13.79%	7,790 $192,000
Q2 2021 Aug 16, 2021	BUY	$19.62 - $29.26 $134,318 - $200,313	6,846 New	6,846 $169,000

Others Institutions Holding RNA

# of Institutions

231

Shares Held

119M

Call Options Held

340K

Put Options Held

145K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.41B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Avidity Biosciences, Inc. Transaction History